The Impact of COVID-19 on Cancer Screenings, Diagnosis, and Treatments
A new study shows cancer services have declined substantially in 2020. What does that mean for patients, practices, and the health care system?
On Friday, October 30th experts from the Community Oncology Alliance (COA) and Avalere Health hosted a webinar discussing the results of an important new study on the impact of COVID-19 on cancer screenings, diagnoses, and treatments.
Released last week and published in the journal JCO Clinical Cancer Informatics, the study shows a considerable drop in cancer screening, diagnosis, and treatment for American seniors and Medicare beneficiaries this year. The study found significant reductions in breast (-85%), colon (-75%), prostate (-74%), and lung cancer (-56%) screenings at the first peak of the pandemic in April 2020, compared with April 2019.
During this webinar, attendees heard more about the study results, analysis of the trends, and perspectives on what the data means for patients with cancer and the providers that treat them. Oncologists who were part of the study’s research team say they are already starting to see the traumatic results, as cancers are caught at later stages requiring more complex treatments, resulting in higher morbidity, or worse, death.
The Impact of COVID-19 on Cancer Screenings, Diagnosis, and Treatments
A new study shows cancer services have declined substantially in 2020. What does that mean for patients, practices, and the health care system?
On Friday, October 30th experts from the Community Oncology Alliance (COA) and Avalere Health hosted a webinar discussing the results of an important new study on the impact of COVID-19 on cancer screenings, diagnoses, and treatments.
Released last week and published in the journal JCO Clinical Cancer Informatics, the study shows a considerable drop in cancer screening, diagnosis, and treatment for American seniors and Medicare beneficiaries this year. The study found significant reductions in breast (-85%), colon (-75%), prostate (-74%), and lung cancer (-56%) screenings at the first peak of the pandemic in April 2020, compared with April 2019.
During this webinar, attendees heard more about the study results, analysis of the trends, and perspectives on what the data means for patients with cancer and the providers that treat them. Oncologists who were part of the study’s research team say they are already starting to see the traumatic results, as cancers are caught at later stages requiring more complex treatments, resulting in higher morbidity, or worse, death.
